Drug intelligence / Profile preview

6'-O-caffeoylarbutin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

6'-O-caffeoylarbutin is a natural phenolic compound and a standardized extract derived from the leaf buds of *Vaccinium dunalianum* Wight, a plant traditionally used in Chinese herbal medicine by the Yi people to treat rheumatism and stimulate blood circulation. Research utilizing zebrafish models has demonstrated that the compound possesses significant hypolipidemic and antithrombotic activities. Network pharmacology and molecular docking studies suggest that its therapeutic effects are mediated through the modulation of several key biological targets, including Matrix metalloproteinase-9 (MMP9), RELA (NF-kappa-B p65 subunit), and Matrix metalloproteinase-2 (MMP2). It is primarily investigated as a bioactive constituent of herbal teas and a potential nutraceutical for cardiovascular health.

Other names
6'-O-caffeoyl arbutin6'-O-caffeoylarbutoside
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)MMP9 (Matrix metalloproteinase-9)TYR (Tyrosinase)MMP2 (Matrix metalloproteinase-2)PRKCA (Protein kinase C alpha)HSP90AA1 (Heat shock protein HSP90-alpha)

Beyond the preview

Go deeper on 6'-O-caffeoylarbutin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6'-O-caffeoylarbutin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call